These results have relevant implications for the understanding of the distinct roles of WAT inflammation in health and obesity-related metabolic diseases, paving the way for the development of new IL-1 modulation strategies for the treatment of obesity-related metabolic diseases. This evidence concerns the gene IL1B and obesity due to melanocortin 4 receptor deficiency.